Live
ePaper
Search
Home > India > BRIEF-Clearmind Achieves Full Enrollment For Part C In Cmnd-100 Phase I/Iia Trial, Marking Key Clinical Milestone

BRIEF-Clearmind Achieves Full Enrollment For Part C In Cmnd-100 Phase I/Iia Trial, Marking Key Clinical Milestone

Written By:
Last Updated: November 16, 2026 18:14:31 IST

Nov 16 (Reuters) – Clearmind Medicine Inc: * CLEARMIND ACHIEVES FULL ENROLLMENT FOR PART C IN CMND-100 PHASE I/IIA TRIAL, MARKING KEY CLINICAL MILESTONE Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?